Private equity firm Lone Star Funds has acquired the Capsules & Health Ingredients (CHI) division of Swiss Contract Development and Manufacturing Organisation (CDMO) Lonza Group for an enterprise value of CHF 2.3 billion (~$3 billion). Headquartered in Basel, Switzerland, the CHI business manufactures capsules used to deliver medicines and dietary supplements. It operates across the Americas, Europe, and the Asia Pacific.



